KORU Medical Systems, Inc. has announced an amendment to its existing loan and security agreement with HSBC Ventures USA Inc., which was originally dated March 8, 2024. The amendment, effective March 30, 2026, extends the maturity of the revolving credit facility of $5 million from December 31, 2026, to March 30, 2028. Additionally, the interest-only period for the term loan of $5 million has been extended from September 30, 2026, to June 30, 2027, with a potential further extension to December 31, 2027, contingent upon achieving certain EBITDA milestones. The maturity date for the term loan has also been pushed back from December 1, 2028, to December 1, 2029. Furthermore, the amendment lowers the interest rate floor for both the revolving credit and term loan from 6.50% to 5.50%. Notably, the adjusted quick ratio covenant has been removed and replaced with a liquidity covenant requiring at least twelve months of liquidity, to be tested monthly once the revolving credit is drawn. This strategic move is expected to enhance KORU's financial flexibility and operational execution, potentially leading to a positive impact on its stock price.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.